Short Description Amazentis develops urolithin a mitochondrial health to address aging and extend healthy lifespan.
Description Amazentis is a leading biotechnology innovator in the longevity ecosystem, focused on urolithin a mitochondrial health as a core strategy for combating age-related decline. The company leverages advances in metabolic & pharmacological longevity and partners with premier research institutions to transform scientific discoveries into real-world interventions. With a mission to add healthy years to life, Amazentis aims to bring evidence‑based solutions from bench to patients and consumers worldwide.
Address EPFL Innovation Park, Bldg A, Lausanne, VD, Switzerland